Finance outlook india logo
Home News Exclusive Expert's Viewpoint Corporate Startup Fintech Personal Magazine About Us Budget'24
  • Budget'26 Budget'25 Budget'24
    • Home
    • News
    SpiceJet CMD Ajay Singh to Inject Rs 294 Crore into Airline through Another Entity

    SpiceJet CMD Ajay Singh to Inject Rs 294 Crore into Airline through Another Entity


    Finance Outlook India Team | Monday, 17 March 2025

    SpiceJet announced on Monday that its founder, Ajay Singh, will infuse Rs 294 crore into the airline through a promoter group entity by converting warrants into equity shares, increasing the promoter group's shareholding to more than 33 percent.

    Singh, the carrier's Chairman and Managing Director, will infuse funds through Spice Healthcare Pvt Ltd, a promoter group company.

    SpiceJet announced on Monday that Singh will invest Rs 294.09 crore in the company by converting 13,14,08,514 warrants into an equivalent number of equity shares (13.14 crore equity shares).

    "This strategic move will increase the consolidated shareholding of the promoter group in SpiceJet from the current 29.11 percent to 33.47 per cent," according to the news release.

    Furthermore, Singh is selling up to 3.15 crore equity shares of the airline, and the proceeds will be used to enable Spice Healthcare Pvt Ltd to partially fund the remaining 75% of the amount at the time of allotment of the equity shares pursuant to the exercise of the option to convert the said warrants.

    Singh's fund infusion is related to a previously announced fundraising plan.

    The SpiceJet board/board committee will meet on or before March 18 to approve the allotment of equity shares in accordance with the exercise of the warrant conversion option, according to a release issued on Monday.

    Singh stated that the investment will help strengthen the airline's financial position and drive growth.

    Against the backdrop of SpiceJet's headwinds, he added that the successful conversion of warrants and subsequent capital infusion represents another significant step in the airline's ongoing turnaround strategy.

    On Thursday, Singh sold nearly 1% of his stake in the budget airline for Rs 52 crore in an open market transaction.

    SpiceJet reported an after-tax profit of Rs 26 crore for the three months ended December 2024, boosted by improved overall performance.

    SpiceJet shares rose more than 4% to Rs 47.30 each in morning trading on the BSE



    Read More:

    Somerset Indus Closes $288 Mn Fund III for Healthcare Bets

    FM Sitharaman Introduces Corporate Laws Amendment Bill 2026

    KNOWLEDGE DECK

    Most Viewed

    • The Economic Impact of India-Pakistan War: A Detailed Analysis

    • Why Financial Literacy Matters More Than Ever for Today's Youth

    • Prominent Financial Advisors in India to Partner With

    • Rags to Riches: The Top 6 Indian Entrepreneurs' Motivational Tales of Success

    • Navigating Financial Disruption With Future Proof Financial Service Deliverability

    • India's Rs 31 Lakh Cr Green Push: Building the Foundation of a Net-Zero Future

    • Wakhariya & Wakhariya: Facilitating International Legal Processes across Diverse Domains

    • Aligning Financial Strategies with Sustainable Business Goals

    • The Top 5 Highest-paid Actors in India - 2024

    • Central Government Proposes Tax on Agricultural Water Usage

    • Carpediem Capital Invests INR 100 Crore, CorporatEdge to Deploy INR 350 Crore in the next 3 Years

    • EPFO Registers All-Time High Member Addition of 20.06 Lakh in May 2025

    • Unearthing Intricacies of Today and Beyond in the Indian Insurance Sector

    • Expected Correction in Housing Prices to Revive Sales in Coming Quarters

    • How to Choose the Right Mutual Fund for your Financial Goals?

    • Future of Corporate Finance: Emerging Trends in Treasury Solutions and Cash Management for MNCs

    • ElasticRun Announces FY24 Financial Results: Key Details

    • Financial Inclusion in Viksit Bharat

    • Abans Financial Services Advises Vaishali Pharma on Strategic Acquisition of Kesar Pharma






    🍪 Do you like Cookies?

    We use cookies to ensure you get the best experience on our website. Read more...

    Copyright © 2026 Finance Outlook India. All rights reserved.   Privacy Policy Terms of Use Blogs Conferences Subscribe WRAPUP’25